Bioasis Technologies (CVE:BTI) Shares Cross Below 50-Day Moving Average – Should You Sell?

Bioasis Technologies Inc. (CVE:BTI) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$0.01 and traded as low as C$0.01. Bioasis Technologies shares last traded at C$0.01, with a volume of 5,250 shares trading hands.

Bioasis Technologies Trading Down 50.0%

The stock has a market cap of C$397,050.00, a PE ratio of -0.13 and a beta of 0.45. The business’s fifty day moving average is C$0.01 and its 200 day moving average is C$0.01. The company has a quick ratio of 0.17, a current ratio of 0.11 and a debt-to-equity ratio of 27.88.

About Bioasis Technologies

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007).